Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  2. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  3. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  4. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  5. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  6. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  7. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  8. 4 Grant or award Director acquired 9,100 shares (grant or award)
  9. 4 Grant or award Director acquired 9,100 shares (grant or award)
  10. 4 Grant or award Director acquired 9,100 shares (grant or award)
  11. 4 Grant or award Director acquired 9,100 shares (grant or award)
  12. 4 Grant or award Director acquired 9,100 shares (grant or award)
  13. 4 Grant or award Director acquired 9,100 shares (grant or award)
  14. 4 Grant or award Director acquired 9,100 shares (grant or award)
  15. 4 Open-market sale SVP, COO & CFO sold 2,000 shares at $19.96 ($39,920)
  16. 4 Open-market sale Director sold 2,250 shares at $19.74 ($44,415)
  17. 4 Open-market sale Director sold 8,000 shares at $18.53 ($148,240)
  18. 4 Exercise or conversion Director acquired 30,000 shares (option exercise)
  19. 4 Open-market sale Chief R&D Officer sold 26,200 shares at $19.67 ($515,354)
  20. 4 Open-market sale SVP & General Counsel sold 1,529 shares at $19.67 ($30,075)

Page 11 of 49 · 970 filings